Okay, let's tackle this question about Erythroblastosis fetalis and hypersensitivity types. First, I need to recall what Erythroblastosis fetalis is. From what I remember, it's a condition in a fetus where there's hemolysis of red blood cells due to blood group incompatibility between the mother and the fetus. The most common cause is Rh incompatibility, where the mother is Rh-negative and the fetus is Rh-positive. The mother's immune system produces antibodies against the Rh antigen, which then cross the placenta and attack the fetal red blood cells.

Now, the question is asking which type of hypersensitivity this is. Hypersensitivity types are categorized into four types: I, II, III, and IV. Type I is IgE-mediated immediate reactions like allergies. Type II is antibody-mediated, usually IgG or IgM against cell surface antigens. Type III is immune complex-mediated, and Type IV is cell-mediated.

Erythroblastosis fetalis involves maternal IgG antibodies crossing the placenta and attacking fetal RBCs. That sounds like a Type II hypersensitivity because it's antibody-mediated targeting of cells. Type II is characterized by antibodies binding to antigens on the cell surface, leading to cell destruction via complement or phagocytosis.

Let me check the other options. Type I would involve IgE, which isn't the case here. Type III involves immune complexes causing inflammation, which isn't happening here. Type IV is T-cell mediated, which also doesn't fit. So the correct answer should be Type II.

The options given don't have the letters filled in, but the correct answer is Type II. The question references past exams (Sep 2007, 2009), so confirming the answer is important. The clinical pearl here is that Rh incompatibility leading to Erythroblastosis fetalis is a classic example of Type II hypersensitivity. Also, understanding the difference between the hypersensitivity types is crucial for these exams. The key is remembering that antibody-mediated cell destruction is Type II, while immune complex is Type III, etc.

**Core Concept**
Erythroblastosis fetalis is an **antibody-mediated hypersensitivity reaction** (Type II) caused by maternal IgG antibodies targeting fetal red blood cells due to Rh or ABO incompatibility. This involves complement activation and phagocytosis of antibody-coated cells.

**Why the Correct Answer is Right**
Type II hypersensitivity occurs when antibodies (IgG or IgM) bind to antigens on cell surfaces, triggering complement-mediated lysis or phagocytosis. In Rh incompatibility, the mother’s IgG anti-D antibodies cross the placenta, bind to fetal Rh+ erythrocytes, activate the classical complement pathway, and cause intravascular hemolysis. This is distinct from Type I (IgE-mediated), III (immune complex), or IV (T-cell mediated) hypersensitivities.

**Why Each Wrong Option is Incorrect**
**Option A:** Type I hypersensitivity (e.g., anaphylaxis) involves IgE and mast cell degranulation—unrelated to erythroblastosis.
**Option B:** Type III hypersensitivity (e.g., serum sickness) involves immune complex deposition, not direct cell destruction.
**Option D:** Type

✓ Correct Answer: B. Type II